| 01/11 | Glaukos Announces Positive Results for iDose TR Exchange Trial Highlighting Favorable S.. | AQ |
| 01/10 | Glaukos : Investor Presentation January 2023 | PU |
| 01/10 | Glaukos Corp : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 01/10 | Glaukos Announces Positive Clinical Updates for Several Corneal Health Pipeline Program.. | BU |
| 01/10 | Glaukos Announces Positive Results for iDose TR Exchange Trial, Highlighting Favorable .. | BU |
| 2022 | Glaukos Announces Participation in the J.P. Morgan Healthcare Conference 2023 | AQ |
| 2022 | Glaukos Announces Participation in the J.P. Morgan Healthcare Conference | BU |
| 2022 | Glaukos Corp : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial .. | AQ |
| 2022 | Glaukos : Investor Presentation November 2022 | PU |
| 2022 | Glaukos Corp : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 2022 | Glaukos Announces Participation in the Stephens Annual Investment Conference | BU |
| 2022 | GLAUKOS CORP Management's Discussion and Analysis of Financial Condition and Results
o.. | AQ |
| 2022 | Glaukos : Q3 Earnings Snapshot | AQ |
| 2022 | Glaukos Corp : Results of Operations and Financial Condition, Regulation FD Disclosure, Fi.. | AQ |
| 2022 | Glaukos Corporation Announces Third Quarter 2022 Financial Results | BU |
| 2022 | Glaukos to Release Third Quarter 2022 Financial Results after Market Close on November .. | BU |
| 2022 | Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Aca.. | BU |
| 2022 | Coupa Software, Glaukos rise; Occidental Petroleum falls | AQ |
| 2022 | Glaukos Corp : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 2022 | Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR.. | BU |
| 2022 | Glaukos Announces More Than 1 Million iStent® Technologies Implanted Worldwide | BU |
| 2022 | Burns & Levinson Represents iVeena Delivery Systems, Inc. in Strategic Licensing Agreem.. | PR |
| 2022 | Glaukos Announces Participation in the Wells Fargo Healthcare Conference | BU |
| 2022 | GLAUKOS CORP Management's Discussion and Analysis of Financial Condition and Results
o.. | AQ |
| 2022 | Glaukos : Q2 Earnings Snapshot | AQ |
| 2022 | Glaukos : Announces Second Quarter 2022 Financial Results - Form 8-K | PU |
| 2022 | Glaukos Corp : Results of Operations and Financial Condition, Regulation FD Disclosure, Fi.. | AQ |
| 2022 | Glaukos Announces FDA 510(k) Clearance of iStent infinite® | BU |
| 2022 | Glaukos Corporation Announces Second Quarter 2022 Financial Results | BU |
| 2022 | Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3 | BU |
| 2022 | Glaukos Corp : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
| 2022 | Glaukos Announces Participation in the William Blair Growth Stock Conference | BU |
| 2022 | Glaukos Corp : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 2022 | Glaukos Announces Participation in the Piper Sandler Virtual Ophthalmology Symposium | BU |
| 2022 | GLAUKOS CORP Management's Discussion and Analysis of Financial Condition and Results
o.. | AQ |
| 2022 | Glaukos : Q1 Earnings Snapshot | AQ |
| 2022 | Glaukos Corp : Results of Operations and Financial Condition, Regulation FD Disclosure, Fi.. | AQ |
| 2022 | Glaukos Corporation Announces First Quarter 2022 Financial Results | BU |
| 2022 | Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Soc.. | BU |
| 2022 | Glaukos Announces the Release of its 2021 Sustainability Report | BU |
| 2022 | Glaukos to Release First Quarter 2022 Financial Results after Market Close on May 4 | BU |
| 2022 | Glaukos Announces Commencement of Phase 2 Corneal Health Clinical Program for Third-Gen.. | BU |
| 2022 | Glaukos : Investor Presentation March 2022 | PU |
| 2022 | Glaukos Corp : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 2022 | GLAUKOS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
O.. | AQ |
| 2022 | Glaukos : Q4 Earnings Snapshot | AQ |
| 2022 | Glaukos : Announces Fourth Quarter and Full Year 2021 Financial Results - Form 8-K | PU |
| 2022 | Glaukos Corp : Results of Operations and Financial Condition, Regulation FD Disclosure, Fi.. | AQ |
| 2022 | Glaukos Corporation Announces Fourth Quarter and Full Year 2021 Financial Results | BU |
| 2022 | Glaukos : Announces Executive Leadership Changes - Form 8-K | PU |
| 2022 | Glaukos Corp : Change in Directors or Principal Officers, Regulation FD Disclosure, Financ.. | AQ |
| 2022 | Glaukos Announces Executive Leadership Changes | BU |
| 2022 | Glaukos Corporation to Release Fourth Quarter and Full Year 2021 Financial Results afte.. | BU |
| 2022 | Glaukos : Investor Presentation January 2022 | PU |
| 2022 | Glaukos Corp : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 2022 | Glaukos' iDose® TR Demonstrates Sustained IOP Reduction and Favorable Safety Profile Ov.. | BU |
| 2022 | Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Dry Eye Disease | BU |
| 2022 | Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Presbyopia | BU |
| 2022 | Glaukos Announces FDA 510(k) Clearance of iPRIME™ | BU |
| 2021 | Glaukos Announces Participation in the J.P. Morgan Healthcare Conference | BU |
| 2021 | Glaukos : Announces Retirement of William J. Link, Ph.D., as Chairman of the Board and Ele.. | PU |
| 2021 | Glaukos Corp : Change in Directors or Principal Officers, Regulation FD Disclosure, Financ.. | AQ |
| 2021 | Glaukos Announces Retirement of William J. Link, Ph.D., as Chairman of the Board and El.. | BU |
| 2021 | Glaukos : Investor Presentation November 2021 | PU |
| 2021 | Glaukos Corp : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) | AQ |
| 2021 | Glaukos Announces Participation in Upcoming Investor Conferences | BU |
| 2021 | Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 American Aca.. | BU |
| 2021 | GLAUKOS CORP Management's Discussion and Analysis of Financial Condition and Results
o.. | AQ |
| 2021 | Glaukos : Q3 Earnings Snapshot | AQ |
| 2021 | Glaukos Corporation Announces Third Quarter 2021 Financial Results - Form 8-K | PU |
| 2021 | GAAP to Non-GAAP Reconciliation Tables – Q3 2021 | PU |
| 2021 | Glaukos Corporation Announces Third Quarter 2021 Financial Results | BU |
| 2021 | Regulation FD Disclosure - Form 8-K | PU |
| 2021 | Glaukos Corp : Regulation FD Disclosure (form 8-K) | AQ |
| 2021 | Glaukos : Investor Presentation August 2021 | PU |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
